The Cromer blood group system: an update

J.R. Storry; C. Lomas-Francis

doi:10.21307/immunohematology-2021-017

.blurhash-client-img { display: none !important; }

The Cromer blood group system: an update

Immunohematology

Volume 37 (2021): Issue 3 (September 2021)

By: J.R. Storry and C. Lomas-Francis

Open Access

|Sep 2021

Abstract

This update of the Cromer (CROM) blood group system (Storry JR, Reid ME, Yazer MH. The Cromer blood group system: a review. Immunohematology 2010;26:109–17) includes additional variants to the Cromer system (ISBT021), both new antigens and new molecular bases underlying the null phenotype. The molecule on which the Cromer blood group antigens are carried, CD55 (DAF), is an important receptor for the malaria parasite, Plasmodium falciparum, and the role of CD55 in health and disease continues to expand.

References

Storry JR, Reid ME, Yazer MH. The Cromer blood group system: a review. Immunohematology 2010;26:109–18.
Search in Google Scholar Back to article
Telen MJ, Rao N, Udani M, Thompson ES, Kaufman RM, Lublin DM. Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology. Blood 1994;84:3205–11.
Search in Google Scholar Back to article
Lublin DM, Mallinson G, Poole J, et al. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 1994;84:1276–82.
Search in Google Scholar Back to article
Lublin DM, Kompelli S, Storry JR, Reid ME. Molecular basis of Cromer blood group antigens. Transfusion 2000;40:208–13.
Search in Google Scholar Back to article
Storry JR, Sausais L, Hue-Roye K, et al. GUTI: a new antigen in the Cromer blood group system. Transfusion 2003;43:340–4.
Search in Google Scholar Back to article
Banks J, Poole J, Ahrens N, et al. SERF: a new antigen in the Cromer blood group system. Transfus Med 2004;14:313–8.
Search in Google Scholar Back to article
Hue-Roye K, Lomas-Francis C, Belaygorod L, et al. Three new high-prevalence antigens in the Cromer blood group system. Transfusion 2007;47:1621–9.
Search in Google Scholar Back to article
Karamatic Crew V, Poole J, Thornton N, et al. Two unusual cases within the Cromer blood group system: I) a novel high incidence antigen Croz and II) a novel molecular basis of Inab phenotype. Transfus Med 2010;20(Suppl 1):12.
Search in Google Scholar Back to article
Karamatic Crew V, Poole J, Mathlouthi R, Wall L, Daniels G. A novel Cromer blood group system antigen, CRUE, arising from two heterozygous DAF mutations in one individual with the corresponding anti-CRUE. Vox Sang 2012;103(Suppl 1):56.
Search in Google Scholar Back to article
Lomas-Francis C, Fuchisawa A, Hamilton J, Hue-Roye K, Pelton SB, Westhoff CM. CRAG: a new high-prevalence antigen in the Cromer blood group system. Vox Sang 2012;103(Suppl 1):211–2.
Search in Google Scholar Back to article
Yahalom V, Finkel L, Poole J, et al. CROK—a novel mutation of the Cromer blood group system. Vox Sang 2012;103(Suppl 1):212.
Search in Google Scholar Back to article
Vrignaud C, Chiaroni J, Landre C, et al. Characterization of a novel high-prevalence antigen in the Cromer blood group system. Vox Sang 2018;113(Suppl 1):64–5.
Search in Google Scholar Back to article
Lomas-Francis C, Wu Y, Fuchisawa A, et al. A new molecular basis (c.148G>T in DAF) for the Cromer-null phenotype in a Yt(a–) MER2 (CROM) proband with anti-IFC. Transfusion 2013;43(Suppl):41A.
Search in Google Scholar Back to article
Holmes CH, Simpson KL, Wainwright SD, et al. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol 1990;144:3099–105.
Search in Google Scholar Back to article
Reid ME, Chandrasekaran V, Sausais L, Pierre J, Bullock R. Disappearance of antibodies to Cromer blood group system antigens during mid pregnancy. Vox Sang 1996;71:48–50.
Search in Google Scholar Back to article
Banadakoppa M, Chauhan MS, Havemann D, Balakrishnan M, Dominic JS, Yallampalli C. Spontaneous abortion is associated with elevated systemic C5a and reduced mRNA of complement inhibitory proteins in placenta. Clin Exp Immunol 2014;177:743–9.
Search in Google Scholar Back to article
Regal JF, Gilbert JS, Burwick RM. The complement system and adverse pregnancy outcomes. Mol Immunol 2015;67: 56–70.
Search in Google Scholar Back to article
Egan ES, Jiang RH, Moechtar MA, et al. Malaria: a forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion. Science 2015;348:711–4.
Search in Google Scholar Back to article
Ozen A, Comrie WA, Lenardo MJ. CD55 deficiency and protein-losing enteropathy. N Engl J Med 2017;377:1499–500.
Search in Google Scholar Back to article
Angeletti A, Marasa M, Cravedi P. CD55 deficiency and protein-losing enteropathy. N Engl J Med 2017;377:1499.
Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.21307/immunohematology-2021-017 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X

Journal RSS Feed

Language: English

Page range: 118 - 121

Published on: Sep 30, 2021

Published by: American National Red Cross

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Cromer,

CROM,

Related subjects:

© 2021 J.R. Storry, C. Lomas-Francis, published by American National Red Cross
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 37 (2021): Issue 3 (September 2021)